171 related articles for article (PubMed ID: 38364733)
1. Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target.
Zang C; Liu H; Ning J; Chen Q; Jiang Y; Shang M; Yang Y; Ma J; Dong Y; Wang J; Li F; Bao X; Zhang D
Biomed Pharmacother; 2024 Mar; 172():116204. PubMed ID: 38364733
[TBL] [Abstract][Full Text] [Related]
2. HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
Rotblat B; Southwell AL; Ehrnhoefer DE; Skotte NH; Metzler M; Franciosi S; Leprivier G; Somasekharan SP; Barokas A; Deng Y; Tang T; Mathers J; Cetinbas N; Daugaard M; Kwok B; Li L; Carnie CJ; Fink D; Nitsch R; Galpin JD; Ahern CA; Melino G; Penninger JM; Hayden MR; Sorensen PH
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3032-7. PubMed ID: 24516159
[TBL] [Abstract][Full Text] [Related]
3. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
[TBL] [Abstract][Full Text] [Related]
4. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
J Virol; 2019 May; 93(9):. PubMed ID: 30787155
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
[TBL] [Abstract][Full Text] [Related]
6. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
8. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
[TBL] [Abstract][Full Text] [Related]
9. HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo.
Ehrnhoefer DE; Southwell AL; Sivasubramanian M; Qiu X; Villanueva EB; Xie Y; Waltl S; Anderson L; Fazeli A; Casal L; Felczak B; Tsang M; Hayden MR
Hum Mol Genet; 2018 Jan; 27(2):239-253. PubMed ID: 29121340
[TBL] [Abstract][Full Text] [Related]
10. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
[TBL] [Abstract][Full Text] [Related]
11. Emerging views of OPTN (optineurin) function in the autophagic process associated with disease.
Qiu Y; Wang J; Li H; Yang B; Wang J; He Q; Weng Q
Autophagy; 2022 Jan; 18(1):73-85. PubMed ID: 33783320
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
[TBL] [Abstract][Full Text] [Related]
14. Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cells.
Yu Z; Li Y; Han T; Liu Z
Oncol Lett; 2019 May; 17(5):4361-4368. PubMed ID: 30988809
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-independent proteasomal degradation of Spindlin-1 by the E3 ligase HACE1 contributes to cell-cell adhesion.
Palicharla VR; Gupta D; Bhattacharya D; Maddika S
FEBS Lett; 2021 Feb; 595(4):491-506. PubMed ID: 33421097
[TBL] [Abstract][Full Text] [Related]
16. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
[TBL] [Abstract][Full Text] [Related]
17. Demethylation of
Li S; Yang H; Zhao M; Gong L; Wang Y; Lv Z; Quan Y; Wang Z
Oncol Lett; 2020 Dec; 20(6):280. PubMed ID: 33014158
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
Liu S; Li X
Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
[TBL] [Abstract][Full Text] [Related]
19. Hace1 overexpression mitigates myocardial hypoxia/reoxygenation injury via the effects on Keap1/Nrf2 pathway.
Chen TY; Zheng SK
In Vitro Cell Dev Biol Anim; 2022 Oct; 58(9):830-839. PubMed ID: 36251153
[TBL] [Abstract][Full Text] [Related]
20. Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
Kim I; Shin SH; Lee JE; Park JW
Oncogene; 2019 May; 38(19):3651-3666. PubMed ID: 30659265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
